CLINICAL_TRIALS
trial_result
· 2021-06-11
Clinical Trial Update: Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3) [Phase 3]
Summary
A Phase 3 trial ASTEROID 3 evaluating vilaprisan in uterine fibroids was terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Uterine Fibroids | Phase 3 | Status: TERMINATED | Results posted: 2021-06-11